Search bioRxiv⌕ Search

Biology subjects

Garcia-Ortiz, I.

Publications and source records attributed to Garcia-Ortiz, I..

2 recordsLinked to original sources

Convergent pathways with impaired inhibition at the frontal cortex are the outcome of differential alterations in the male and female schizophrenia model

Schizophrenia is associated with impaired inhibitory neurotransmission and disrupted synaptic plasticity in the medial prefrontal cortex (mPFC), yet the biological mechanisms underlying these deficits may differ between sexes. Here, we used a double-hit rat model, combining perinatal NMDA receptor blockade and post-weaning social isolation, to dissect sex-specific alterations in inhibitory circuit maturation, synaptic plasticity, and prefrontal function. Male double-hit rats exhibited robust schizophrenia-like behaviors, reduced parvalbumin (PV), OTX2, and perineuronal net (PNN) expression, decreased GAD67 levels, and increased DNA damage in PV interneurons, together indicating impaired inhibitory maturation and weakened plasticity. In contrast, females showed milder behavioral deficits but displayed increased PV and OTX2 intensities, enhanced cFos activation in excitatory neurons, and transcriptomic upregulation of glutamatergic, GABAergic, and synapse assembly pathways, suggesting a state of heightened or dysregulated plasticity. Despite these divergent molecular trajectories, in vivo electrophysiology revealed a shared functional endpoint in both sexes: a shift from paired-pulse inhibition to facilitation during basolateral amygdala-evoked responses, reflecting impaired GABAB-mediated inhibitory feedback. Pharmacological blockade of GABAB, but not GABAA, receptors reproduced this phenotype, identifying GABAB signaling as a key mechanism underlying cortical disinhibition. Altogether, our findings reveal that males and females reach convergent prefrontal inhibitory deficits through sex-specific molecular pathways, underscoring the importance of sex as a biological variable in the pathophysiology and treatment of schizophrenia.

neuroscience↗

TAF1-dependent transcriptional dysregulation underlies multiple sclerosis

A major conceptual and clinical challenge in multiple sclerosis (MS) is understanding the mechanisms that drive the central nervous system (CNS)-resident neuroinflammation and neurodegeneration underneath disease progression. Genome-wide association studies (GWAS) have implicated RNA polymerase II (RNAPII) promoter-proximal pausing in oligodendrocyte pathology, but the causal mechanisms remain unclear. Here we find that the C-terminal region of TAF1, a core component of the general transcription factor TFIID, is underdetected in progressive MS brains, which can be explained by endoproteolysis due to extralysosomal cathepsin B (CTSB). Mice lacking the C-terminal TAF1 domain (Taf1d38) exhibit MS-like brain transcriptomic signature, alongside CNS-resident inflammation, progressive demyelination, and motor disability. Mechanistically, C-terminal TAF1 interacts with MS-linked factors that cooperate to regulate RNAPII pausing, particularly affecting oligodendroglial myelination genes. These findings uncover a previously unrecognized transcriptional mechanism underlying MS progression and establish a tractable in vivo model for therapeutic development.

neuroscience↗